Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea
Advances in GLP-1 receptor agonists for pain treatment: neuroprotective and metabolic regulatory mechanisms
And what I found was incredible
Financial costs, an excessive number of patients, and a shortage of specialised health care professionals are among the main obstacles towards the enforcement of the CMC model ( Publishers Note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) slow gastrointestinal transit, causing constipation in up to 1 in 10 patients
12 An additional case of a 73-year-old male patient with chronic obstructive pulmonary disease (COPD), Class III obesity and T2DM demonstrated rapid resolution of severe psoriasis with improved glycemic control and reduced body weight
